[Skip to main content] [Skip to secondary navigation]

RNS Announcements

1  2  3  4  5  6  7  8  9  10  11  12   < Previous Next >

  • Issue of equity and unlisted warrants 24-09-07

    The Company announces that at a Board meeting held on 21st September 2007, under the terms of the facility agreement dated 2 September 2006, 411,765 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €1.02 per Ordinary Share and 164,706 Unlisted Warrants were granted with an exercise price of GBP 0.82 per share.

  • Antonov Interim Results 21-09-07

    Antonov Chief Executive said: “We have made encouraging progress over the period with our engineering programmes. Our additional funding facility is now in place and with a new development centre on line shortly, we now have the infrastructure to underpin both current and future programmes. I look forward to updating shareholders on further progress in due course.”

  • Issue of equity 17-09-07

    The Company announces that at a Board meeting held on 14th September 2007, under the terms of the facility agreement dated 2 September 2006, 446,809 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.94 per Ordinary Share and 178,724 Unlisted Warrants were granted with an exercise price of £0.74 per share.

  • Issue of equity and unlisted warrants 13-09-07

    The Company announces that at a Board meeting held on 11th September 2007, under the terms of the facility agreement dated 2 September 2006, 446,809 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.94 per Ordinary Share and 178,724 Unlisted Warrants were granted with an exercise price of £0.73 per share.

  • Issue of equity and unlisted warrants 06-09-07

    The Company announces that at a Board meeting held on 4th September 2007, under the terms of the facility agreement dated 2 September 2006, 449,198 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.94 per Ordinary Share and 179,679 Unlisted Warrants were granted with an exercise price of £0.72 per share.

  • Issue of equity 31-08-07

    The Company announces that at a Board meeting held on 29 August 2007, under the terms of the facility agreement dated 2 September 2006, 460,526 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.95 per Ordinary Share and 184,210 Unlisted Warrants were granted with an exercise price of £0.74 per share.

  • Issue of equity 10-08-07

    The Company announces that at a Board meeting held on 8 August 2007, under the terms of the facility agreement dated 28 July 2006, 306,592 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.98 per Ordinary Share.

  • Issue of equity 09-08-07

    The Company announces that at a Board meeting held on 31 July 2007, under the terms of the facility agreement with Quivest BV dated 27 July 2007, 776,700 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €1.03 per Ordinary Share.

  • Issue of equity 22-06-07

    The Company announces that at a Board meeting held on 21 June 2007, under the terms of the facility agreement dated 2 September 2006, 139,350 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €1.12 per Ordinary Share and 55,740 Unlisted Warrants were granted with an exercise price of £0.91 per share.

  • Issue of equity 14-06-07

    The Company announces that at a Board meeting held on 13 June 2007, under the terms of the facility agreement dated 2 September 2006, 179,303 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €1.17 per Ordinary Share and 71,721 Unlisted Warrants were granted with an exercise price of £0.91 per share.

1  2  3  4  5  6  7  8  9  10  11  12   < Previous Next >